Fig. 14From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisThe significant low-expression of lncRNA XIST in the GC samples, based on the GEPIA2 relative expression analysisBack to article page